/ Report Details / Biopharmaceutical and Biomedicine Market

Biopharmaceutical and Biomedicine Market, By Product Type (Monoclonal Antibodies and Nanomedicine), By Application, By Therapeutic Area, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

Report Code: AV1982

Industry: Healthcare

Publiced On: 2024-05-25

Pages: 367

Format: ppt pdf

REPORT HIGHLIGHT

Biopharmaceutical and Biomedicine Market size was valued at USD 621,312 Million in 2023, expanding at a CAGR of 9.5% from 2024 to 2032.

The biopharmaceutical and biomedicine market covers the development, production, and commercialization of pharmaceuticals and medical products derived from biological sources. Key drivers in this market include the growing adoption of precision medicine and personalized therapies, advancements in biotechnology such as gene editing and cell therapy, and increased focus on rare diseases and orphan drugs. However, challenges include stringent regulatory requirements, high research and development costs, and difficulties related to manufacturing and scaling up production. Nonetheless, opportunities exist in emerging markets, expansion into therapeutic areas with unmet medical needs, and strategic collaborations and partnerships for drug discovery and development.

Market Dynamics of Biopharmaceutical and Biomedicine:

The sector is experiencing a surge in product launches and approvals, reflecting rapid innovation and expansion. Regulatory bodies like the U.S. Food and Drug Administration (FDA) have reported a steady increase in approvals for biopharmaceutical products, highlighting the industry\'s commitment to addressing unmet medical needs and improving patient outcomes through groundbreaking products.

SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Ø Amgen Inc.
Ø F. Hoffmann-La Roche Ltd
Ø Johnson & Johnson Services, Inc.
Ø Pfizer Inc.
Ø Sanofi
Ø Eli Lilly and Company
Ø AbbVie Inc.
Ø Novo Nordisk A/S
Ø Bristol-Myers Squibb Company
Ø NanoString
Ø QIAGEN
Ø Affimed GmbH
Ø GSK plc.
Ø Merck KgaA
Ø Teva Pharmaceutical Industries Ltd.
Ø Others
GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
Ø Monoclonal Antibodies
o Vaccines
o Recombinant Human Insulin
o Human Growth Hormone
o Erythropoietin
o Interferon
o Others
Ø Nanomedicine
o Cell & Gene Therapy
o Bioinformatics
o Molecular Enzymes & Kits  
GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Ø Therapeutics
Ø Diagnostics
Ø Research and Development
GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032
Ø Oncology
Ø Neurology
Ø Cardiology
Ø Immunology
Ø Infectious Diseases
Ø Rare Diseases
GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
Ø North America
o The U.S.
o Canada
Ø Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Ø Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Ø Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
Ø The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA

TABLE OF CONTENT
1. Biopharmaceutical and Biomedicine Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Biopharmaceutical and Biomedicine Market Snippet by Product Type
2.1.2. Biopharmaceutical and Biomedicine Market Snippet by Application
2.1.3. Biopharmaceutical and Biomedicine Market Snippet by Therapeutic Area
2.1.4. Biopharmaceutical and Biomedicine Market Snippet by Country
2.1.5. Biopharmaceutical and Biomedicine Market Snippet by Region
2.2. Competitive Insights
3. Biopharmaceutical and Biomedicine Key Market Trends
3.1. Biopharmaceutical and Biomedicine Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Biopharmaceutical and Biomedicine Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Biopharmaceutical and Biomedicine Market Opportunities
3.4. Biopharmaceutical and Biomedicine Market Future Trends
4. Biopharmaceutical and Biomedicine Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Biopharmaceutical and Biomedicine Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Biopharmaceutical and Biomedicine Market Landscape
6.1. Biopharmaceutical and Biomedicine Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Biopharmaceutical and Biomedicine Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
7.1.2. Monoclonal Antibodies
7.1.2.1. Vaccines
7.1.2.2. Recombinant Human Insulin
7.1.2.3. Human Growth Hormone
7.1.2.4. Erythropoietin
7.1.2.5. Interferon
7.1.2.6. Others
7.1.3. Nanomedicine
7.1.3.1. Cell & Gene Therapy
7.1.3.2. Bioinformatics
7.1.3.3. Molecular Enzymes & Kits  
8. Biopharmaceutical and Biomedicine Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
8.1.2. Therapeutics
8.1.3. Diagnostics
8.1.4. Research and Development
9. Biopharmaceutical and Biomedicine Market – By Therapeutic Area
9.1. Overview
9.1.1. Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
9.1.2. Oncology
9.1.3. Neurology
9.1.4. Cardiology
9.1.5. Immunology
9.1.6. Infectious Diseases
9.1.7. Rare Diseases
10. Biopharmaceutical and Biomedicine Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Biopharmaceutical and Biomedicine Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Biopharmaceutical and Biomedicine Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Biopharmaceutical and Biomedicine Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Biopharmaceutical and Biomedicine Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Biopharmaceutical and Biomedicine Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Biopharmaceutical and Biomedicine Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Amgen Inc.
11.2.2. F. Hoffmann-La Roche Ltd
11.2.3. Johnson & Johnson Services, Inc.
11.2.4. Pfizer Inc.
11.2.5. Sanofi
11.2.6. Eli Lilly and Company
11.2.7. AbbVie Inc.
11.2.8. Novo Nordisk A/S
11.2.9. Bristol-Myers Squibb Company
11.2.10. NanoString
11.2.11. QIAGEN
11.2.12. Affimed GmbH
11.2.13. GSK plc.
11.2.14. Merck KgaA
11.2.15. Teva Pharmaceutical Industries Ltd.
11.2.16. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

Choose License Type
assit assit

Tailor made solution just for you

80% of our clients seek made-to-order reports. how do you want us to tailor yours?
📧 Talk to Analyst

We have 24/7 dedicated support team.

Get in Touch

© 2023. All rights reserved: AnalystView Market Insights